Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]    
Revenues $ 66,434,000 $ 60,824,000
Cost of sales 44,694,000 43,591,000
Gross profit 21,740,000 17,233,000
Operating expenses:    
Selling and administrative 22,304,000 18,932,000
Research and development 4,464,000 4,916,000
Total operating expenses 26,768,000 23,848,000
Operating loss (5,028,000) (6,615,000)
Other income (expense):    
Interest income (expense), net (1,646,000) (1,718,000)
Net loss $ (6,674,000) $ (8,333,000)
Net loss per share - basic $ (0.40) $ (0.50)
Net loss per share - diluted $ (0.40) $ (0.50)
Weighted average number of common shares outstanding - basic 16,717,761 16,548,533
Weighted average number of common shares outstanding - diluted 16,717,761 16,548,533